|
TL307162V
|
OriGene Technologies
|
Signal peptide peptidase like 2B (SPPL2B) Human shRNA Lentiviral Particle (Locus ID 56928)
|
|
|
|
|
TL311115V
|
OriGene Technologies
|
Natriuretic Peptide Receptor C (NPR3) Human shRNA Lentiviral Particle (Locus ID 4883)
|
|
|
|
|
TL318791V
|
OriGene Technologies
|
Tuberoinfundibular peptide (PTH2) Human shRNA Lentiviral Particle (Locus ID 113091)
|
|
|
|
|
TL318939V
|
OriGene Technologies
|
Peptide YY (PYY) Human shRNA Lentiviral Particle (Locus ID 5697)
|
|
|
|
|
TL319538V
|
OriGene Technologies
|
Gastrin Releasing Peptide (GRP) Human shRNA Lentiviral Particle (Locus ID 2922)
|
|
|
|
|
TL320433V
|
OriGene Technologies
|
Natriuretic Peptide Receptor A (NPR1) Human shRNA Lentiviral Particle (Locus ID 4881)
|
|
|
|
|
TL320434V
|
OriGene Technologies
|
Natriuretic Peptide Receptor B (NPR2) Human shRNA Lentiviral Particle (Locus ID 4882)
|
|
|
|
|
LC422879
|
OriGene Technologies
|
Gastrin Releasing Peptide (GRP) (NM_001012513) Human Over-expression Lysate
|
|
|
|
|
LC419540
|
OriGene Technologies
|
Gastrin Releasing Peptide (GRP) (NM_002091) Human Over-expression Lysate
|
|
|
|
|
LC424461
|
OriGene Technologies
|
Natriuretic Peptide Receptor A (NPR1) (NM_000906) Human Over-expression Lysate
|
|
|
|
|
LC418262
|
OriGene Technologies
|
Natriuretic Peptide Receptor B (NPR2) (NM_003995) Human Over-expression Lysate
|
|
|
|
|
LC424462
|
OriGene Technologies
|
Natriuretic Peptide Receptor C (NPR3) (NM_000908) Human Over-expression Lysate
|
|
|
|
|
P10100
|
OriGene Technologies
|
Delta Opioid Receptor (OPRD1) (aa3-17) Control Peptide) Polyclonal Antibody
|
|
|
|
|
HY-P2198-1mg
|
MedChemexpress LLC
|
PAMP-12(human, porcine) [CAS 196305-05-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2198-5mg
|
MedChemexpress LLC
|
PAMP-12(human, porcine) [CAS 196305-05-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1311-1mg
|
MedChemexpress LLC
|
RLLFT-NH2 [CAS 447408-68-6]
|
|
|
|
|
HY-P0301A-1mg
|
MedChemexpress LLC
|
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P0301A-10mg
|
MedChemexpress LLC
|
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P0301A-5mg
|
MedChemexpress LLC
|
SLLK, Control Peptide for TSP1 Inhibitor(TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P2307-1mg
|
MedChemexpress LLC
|
Tat-NR2Baa [CAS 847829-41-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-P2307-10mg
|
MedChemexpress LLC
|
Tat-NR2Baa [CAS 847829-41-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-P2307-5mg
|
MedChemexpress LLC
|
Tat-NR2Baa [CAS 847829-41-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-P5119A-1mg
|
MedChemexpress LLC
|
Tat-peptide control 168-189 (TFA)
|
|
|
|
|
HY-P3460A-1mg
|
MedChemexpress LLC
|
TDSRCVIGLYHPPLQVY (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P3460A-10mg
|
MedChemexpress LLC
|
TDSRCVIGLYHPPLQVY (TFA)
|
|
COVID-19-immunoregulation
|
|
